256 related articles for article (PubMed ID: 27340869)
21. Deregulation of the HOXA9/MEIS1 axis in acute leukemia.
Collins CT; Hess JL
Curr Opin Hematol; 2016 Jul; 23(4):354-61. PubMed ID: 27258906
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
Chen Y; Ernst P
Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857
[TBL] [Abstract][Full Text] [Related]
23. MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.
Roychoudhury J; Clark JP; Gracia-Maldonado G; Unnisa Z; Wunderlich M; Link KA; Dasgupta N; Aronow B; Huang G; Mulloy JC; Kumar AR
Blood; 2015 Apr; 125(16):2544-52. PubMed ID: 25740828
[TBL] [Abstract][Full Text] [Related]
24. Nuclear FGFR2 Interacts with the MLL-AF4 Oncogenic Chimera and Positively Regulates
Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Cattaneo F; Ammendola R; Esposito G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924850
[TBL] [Abstract][Full Text] [Related]
25. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9.
Ayton PM; Cleary ML
Genes Dev; 2003 Sep; 17(18):2298-307. PubMed ID: 12952893
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation.
Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Salvatore F; Esposito G
Cell Oncol (Dordr); 2019 Dec; 42(6):829-845. PubMed ID: 31493143
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms of MLL-associated leukemia.
Yokoyama A
Int J Hematol; 2015 Apr; 101(4):352-61. PubMed ID: 25773519
[TBL] [Abstract][Full Text] [Related]
28. Regulation of endometrial receptivity by the highly expressed HOXA9, HOXA11 and HOXD10 HOX-class homeobox genes.
Xu B; Geerts D; Bu Z; Ai J; Jin L; Li Y; Zhang H; Zhu G
Hum Reprod; 2014 Apr; 29(4):781-90. PubMed ID: 24549215
[TBL] [Abstract][Full Text] [Related]
29. A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.
Li A; Yang Y; Gao C; Lu J; Jeong HW; Liu BH; Tang P; Yao X; Neuberg D; Huang G; Tenen DG; Chai L
J Clin Invest; 2013 Oct; 123(10):4195-207. PubMed ID: 24051379
[TBL] [Abstract][Full Text] [Related]
30. HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia.
Whelan JT; Ludwig DL; Bertrand FE
Leukemia; 2008 Jun; 22(6):1161-9. PubMed ID: 18337761
[TBL] [Abstract][Full Text] [Related]
31. Identification of a HoxA10 activation domain necessary for transcription of the gene encoding beta3 integrin during myeloid differentiation.
Bei L; Lu Y; Bellis SL; Zhou W; Horvath E; Eklund EA
J Biol Chem; 2007 Jun; 282(23):16846-59. PubMed ID: 17439948
[TBL] [Abstract][Full Text] [Related]
32. HoxA10 influences protein ubiquitination by activating transcription of ARIH2, the gene encoding Triad1.
Wang H; Bei L; Shah CA; Horvath E; Eklund EA
J Biol Chem; 2011 May; 286(19):16832-45. PubMed ID: 21454682
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
[TBL] [Abstract][Full Text] [Related]
34. Frat2 mediates the oncogenic activation of Rac by MLL fusions.
Walf-Vorderwülbecke V; de Boer J; Horton SJ; van Amerongen R; Proost N; Berns A; Williams O
Blood; 2012 Dec; 120(24):4819-28. PubMed ID: 23074275
[TBL] [Abstract][Full Text] [Related]
35. Tip60 activates Hoxa9 and Meis1 expression through acetylation of H2A.Z, promoting MLL-AF10 and MLL-ENL acute myeloid leukemia.
Yamagata K; Shino M; Aikawa Y; Fujita S; Kitabayashi I
Leukemia; 2021 Oct; 35(10):2840-2853. PubMed ID: 33967269
[TBL] [Abstract][Full Text] [Related]
36. HoxA10 regulates transcription of the gene encoding transforming growth factor beta2 (TGFbeta2) in myeloid cells.
Shah CA; Wang H; Bei L; Platanias LC; Eklund EA
J Biol Chem; 2011 Jan; 286(4):3161-76. PubMed ID: 21087928
[TBL] [Abstract][Full Text] [Related]
37. Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.
Largeot A; Paggetti J; Broséus J; Aucagne R; Lagrange B; Martin RZ; Berthelet J; Quéré R; Lucchi G; Ducoroy P; Bastie JN; Delva L
Biochim Biophys Acta; 2013 Dec; 1833(12):3054-3063. PubMed ID: 23994619
[TBL] [Abstract][Full Text] [Related]
38. The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML.
Heikamp EB; Henrich JA; Perner F; Wong EM; Hatton C; Wen Y; Barwe SP; Gopalakrishnapillai A; Xu H; Uckelmann HJ; Takao S; Kazansky Y; Pikman Y; McGeehan GM; Kolb EA; Kentsis A; Armstrong SA
Blood; 2022 Feb; 139(6):894-906. PubMed ID: 34582559
[TBL] [Abstract][Full Text] [Related]
39. Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia.
Kumar AR; Hudson WA; Chen W; Nishiuchi R; Yao Q; Kersey JH
Blood; 2004 Mar; 103(5):1823-8. PubMed ID: 14615372
[TBL] [Abstract][Full Text] [Related]
40. The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice.
Kong CT; Sham MH; So CW; Cheah KS; Chen SJ; Chan LC
Leukemia; 2006 Oct; 20(10):1829-39. PubMed ID: 16888613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
